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  3 - and   2 -chains from the squamous carcinoma cell line SCC25), 
recombinant 230-kDa BP antigen (BP230) and 180-kDa BP anti-
gen (BP180; baculoprotein expression system) as previously de-
scribed  [4] . By ELISA, there was strong IgG reactivity against 
laminin 332 and reactivity against a distinct BP180 epitope (mid-
portion of the BP180 ectodomain, aa residues 809–1106). The le-
sion healed with topical corticosteroids. Three years later, the 
patient was in complete remission, and a control ELISA no longer 
showed IgG reactivity against laminin 332, BP180 or BP230 an-
tigens.
 Case 2 
 A 74-year-old man had a 2-year history of erosions and crusts 
of the scalp. At presentation, he had an erosive and crusty lesion 
10 cm in diameter on the top of his head while other parts of the 
body or mucous membranes were not affected ( fig. 1 b). The bi-
opsy showed actinic damage of the epidermis; the diagnosis of 
actinic keratosis was established, and the lesion was treated with 
liquid nitrogen with only temporary effect. A second biopsy of 
lesional skin showed subepidermal cleavage and an inflammatory 
infiltrate composed of lymphocytes and histiocytes in the dermis 
suggestive of CP ( fig. 1 c). DIF of lesional skin was negative, IIF on 
monkey oesophagus showed granular antinuclear auto-antibod-
ies at a titre of 1: 80 and weak linear positivity with anti-IgG, -A 
and -M antibodies; salt split skin was negative. By ELISA, the pa-
tient’s serum showed IgG reactivity against laminin 332. Topical 
treatment with corticosteroids led to a temporary healing of the 
lesion. Two years later, the patient still needs intermittent topical 
corticosteroid treatment.
 Discussion 
 Brunsting-Perry pemphigoid typically affects elderly men as 
multiple erosive and scarring lesions in the head and neck region, 
rarely as a solitary plaque  [5] . In case of a solitary lesion the diag-
nosis may be extremely difficult. These cases can be misdiag-
nosed as actinic keratosis, pyoderma or dermatitis artefacta. The 
lesion is often eroded; thus, no subepidermal blister is detected, 
eosinophils are usually absent, immunofluorescence studies, if 
done, can be negative.
 A case of Brunsting-Perry pemphigoid similar to ours with a 
solitary lesion of the scalp was described by Poon and McGrath 
 [6] , which was negative by DIF and IIF. Monihan et al. [7] de-
scribed 3 cases of CP simulating basal cell carcinoma. Murata et 
al.  [8] detected immunoglobulin deposits between basal keratino-
cytes and the lamina lucida of the dermal-epidermal junction by 
immuno-electron microscopy in a case of Brunsting-Perry pem-
phigoid supporting the concept that this disorder is closely re-
lated to CP.
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 A scarring disease localized to the head and neck without mu-
cosal involvement, described by Brunsting and Perry in 1957  [1] , 
is considered as a variant of cicatricial pemphigoid (CP), bullous 
pemphigoid (BP) or epidermolysis bullosa acquisita (EBA), al-
though the target antigen has not yet been clearly established. In 
this report, we describe 2 patients with localized CP of the scalp 
and IgG auto-antibodies against laminin 332. Laminin 332 (for-
merly laminin 5) is a target antigen of one subset of CP affecting 
mucous membranes (mucous membrane pemphigoid, MMP)  [2] . 
It is considered rather specific for this subset of MMP and is de-
tected rarely in subepidermal bullous dermatoses affecting the 
skin  [3] .
 Case 1 
 A 58-year-old man presented with a 2-year history of a scar-
ring and crusty lesion 3 cm in diameter in the parietal scalp re-
gion. Basal cell carcinoma was suspected, and a biopsy of the le-
sion was performed. Histological examination showed erosion 
with an inflammatory infiltrate and a few yeast cells (Grocott 
stain). However, topical therapy with antibiotics and antimycot-
ics was not effective. A second skin biopsy revealed subepidermal 
cleavage, erythrocytes in the blister and an inflammatory der-
mal infiltrate of lymphocytes and histiocytes suggestive of CP 
( fig. 1 a). Direct immunofluorescence microscopy (DIF) of lesion-
al skin showed weak linear positivity with anti-IgG antibody; 
indirect immunofluorescence (IIF) on monkey oesophagus was 
negative. A salt split skin test was not performed. Eventually, en-
zyme-linked immunosorbent assay (ELISA) was performed with 
native human laminin 332 (affinity-purified protein with   3 -, 
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 Kurzhals et al.  [9] described a case with clinical features of 
Brunsting-Perry pemphigoid with an immunofluorescence and 
immuno-electron microscopy pattern identical to EBA. This 
finding has also been reported by others  [10, 11] .
 Daito et al.  [12] have recently detected IgG auto-antibodies 
against the COOH terminus of BP180 by immunoblot and bor-
derline positivity of auto-antibodies against the BP180 NC16a do-
main by ELISA in a woman with Brunsting-Perry pemphigoid of 
the scalp and upper trunk involvement. Antibodies against lam-
inin 332 have not been reported in association with Brunsting-
Perry pemphigoid, yet. ELISA is a sensitive and specific tool for 
the detection of anti-laminin-332 antibodies. In the study of Be-
kou et al.  [13] , ELISA with native laminin 332 in MMP had a sen-
sitivity of 75% and a specificity of 84.3%. Bekou et al.  [13] also 
detected anti-laminin-332 antibodies in 40% of patients with BP. 
Anti-laminin-332 antibodies can occur in BP and CP due to the 
epitope spreading phenomenon; laminin 332 is a ligand for BP180 
 [14] , and the BP180 COOH terminus is considered as a target an-
tigen in CP.
 In conclusion, our 2 patients presented here strongly suggest 
that CP of the head, neck and upper trunk without mucosal in-
volvement is a heterogeneous disorder with several target anti-
gens. In addition to the auto-antigens of EBA and BP, IgG auto-
antibodies against a major auto-antigen of MMP, laminin 332, 
may play an important pathogenetic role, especially in the solitary 
lesions of the scalp. Further studies are needed to confirm the rel-
evance of anti-laminin-332 antibodies in Brunsting-Perry pem-
phigoid.
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 Fig. 1.  a Subepidermal blister, case 1. Haematoxylin-eosin. Origi-
nal magnification  ! 100.  b Crusts and erosion on the top of the 
head, case 2.  c Denuded dermis with remnants of epidermis, sub-
epidermal cleft, case 2. Haematoxylin-eosin. Original magnifica-
tion  ! 200. 
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